GOLFIERI, RITA
 Distribuzione geografica
Continente #
EU - Europa 37.180
NA - Nord America 36.372
AS - Asia 35.371
SA - Sud America 2.521
Continente sconosciuto - Info sul continente non disponibili 2.408
AF - Africa 2.203
OC - Oceania 65
Totale 116.120
Nazione #
US - Stati Uniti d'America 35.595
IT - Italia 16.055
VN - Vietnam 10.406
SG - Singapore 9.434
CN - Cina 7.678
GB - Regno Unito 5.025
DE - Germania 3.593
HK - Hong Kong 2.502
SE - Svezia 2.360
NL - Olanda 2.320
FR - Francia 1.867
BR - Brasile 1.840
IN - India 1.697
RU - Federazione Russa 1.402
IE - Irlanda 1.058
FI - Finlandia 722
BD - Bangladesh 676
JP - Giappone 635
ZA - Sudafrica 635
KR - Corea 615
CH - Svizzera 542
UA - Ucraina 529
CI - Costa d'Avorio 482
TG - Togo 473
EE - Estonia 440
CA - Canada 385
BG - Bulgaria 277
AR - Argentina 243
JO - Giordania 238
PH - Filippine 213
ID - Indonesia 206
SC - Seychelles 205
AT - Austria 184
TH - Thailandia 171
NG - Nigeria 166
PL - Polonia 149
TR - Turchia 143
MX - Messico 139
IQ - Iraq 129
BE - Belgio 120
EC - Ecuador 116
ES - Italia 116
PK - Pakistan 101
TW - Taiwan 97
CL - Cile 80
CO - Colombia 71
GR - Grecia 67
MY - Malesia 61
SA - Arabia Saudita 60
EG - Egitto 59
UZ - Uzbekistan 59
IR - Iran 52
PY - Paraguay 52
VE - Venezuela 52
AU - Australia 51
HN - Honduras 50
HR - Croazia 50
JM - Giamaica 45
MA - Marocco 41
RO - Romania 39
LT - Lituania 37
LB - Libano 35
CR - Costa Rica 34
CZ - Repubblica Ceca 30
PE - Perù 29
DZ - Algeria 28
AL - Albania 24
HU - Ungheria 23
KE - Kenya 23
TN - Tunisia 23
AE - Emirati Arabi Uniti 20
UY - Uruguay 19
DK - Danimarca 18
ET - Etiopia 18
BZ - Belize 17
OM - Oman 17
PT - Portogallo 17
RS - Serbia 17
NI - Nicaragua 16
SI - Slovenia 16
BO - Bolivia 15
NP - Nepal 15
GT - Guatemala 14
KZ - Kazakistan 14
SK - Slovacchia (Repubblica Slovacca) 14
TT - Trinidad e Tobago 14
IL - Israele 13
AZ - Azerbaigian 12
DO - Repubblica Dominicana 11
KG - Kirghizistan 10
LU - Lussemburgo 10
MK - Macedonia 10
SV - El Salvador 10
SY - Repubblica araba siriana 10
GH - Ghana 9
NO - Norvegia 9
EU - Europa 8
LV - Lettonia 8
MD - Moldavia 8
NZ - Nuova Zelanda 8
Totale 113.551
Città #
Singapore 6.507
Southend 4.341
Ashburn 3.710
Fairfield 2.756
San Jose 2.476
Ho Chi Minh City 2.391
Chandler 2.370
Hong Kong 2.347
Hanoi 2.069
Santa Clara 1.594
Bologna 1.532
Milan 1.429
Houston 1.341
Princeton 1.254
Wilmington 1.147
Dong Ket 1.070
Woodbridge 1.065
Hefei 1.053
Dublin 1.035
Rome 1.010
Seattle 1.000
Council Bluffs 976
Beijing 960
Cambridge 863
Boardman 861
Lauterbourg 824
Los Angeles 653
Kerkrade 650
Ann Arbor 612
Helsinki 592
Frankfurt am Main 591
New York 574
Tokyo 537
Seoul 504
Westminster 489
Abidjan 482
Lomé 473
Dallas 451
Nanjing 408
Turin 394
Munich 379
Da Nang 357
Florence 350
Bern 346
Eygelshoven 337
Berlin 328
Buffalo 326
Medford 325
Naples 317
Haiphong 310
Saint Petersburg 270
Sofia 264
São Paulo 263
Redondo Beach 254
Jinan 249
Amman 233
San Diego 224
Shenyang 209
Bari 208
Padova 207
Guangzhou 198
Shanghai 167
Palermo 166
Redmond 160
Chicago 158
Changsha 156
Phoenix 150
The Dalles 147
Dearborn 146
Abeokuta 143
Hebei 140
Hải Dương 139
Bremen 130
Tianjin 129
Johannesburg 128
Genoa 122
Nanchang 121
Olalla 120
Biên Hòa 118
London 117
Amsterdam 113
Orem 113
Jacksonville 110
Zhengzhou 110
Bengaluru 106
Des Moines 103
Verona 101
Nuremberg 99
Modena 98
Atlanta 97
Brussels 97
Falls Church 97
Falkenstein 96
Jakarta 95
Jiaxing 95
Norwalk 94
Parma 91
Vienna 91
Can Tho 90
Montreal 90
Totale 65.988
Nome #
Tre casi di cisti di Nuck a presentazione insolita: una sfida diagnostica 5.365
IMAGING DELLE PATOLOGIE VASCOLARI EPATICHE 3.089
3D FIESTA pulse sequence for assessing renal artery stenosis: is it a reliable application in unenhanced magnetic resonance angiography? 1.724
EPATOCARCINOMA E COLANGIOCARCINOMA 1.169
Gestione del rischio clinico in radiologia. Parte I: inquadramento generale, tipologie di errore e loro prevenzione 708
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 689
MANUALE di TC per TSRM 648
PSEUDOLESIONI DA FLUSSO E VERE LESIONI NODULARI FLUSSODIPENDENTI 551
Il referto strutturato in Entero-TC: nostra esperienza preliminare 550
Utilizzo delle sequenze FIESTA (Fast Imaging Steady-state Acquisition) nella diagnosi di stenosi delle arterie renali 490
Outcomes and survival after TIPS positioning: a single center experience 409
Frequency and clinical impact of Dolichocolon in women submitted to surgery for rectosigmoid endometriosis 391
Radiomic Features from Post-Operative 18F-FDG PET/CT and CT Imaging Associated with Locally Recurrent Rectal Cancer: Preliminary Findings 349
BASI SCIENTIFICHE E TECNOLOGICHE PER LA DEFINIZIONE DI LINEE GUIDA DI TERAPIE LOCO-REGIONALI INTEGRATE (TLRI) NELLE PATOLOGIE ONCOLOGICHE 348
Augmented Reality to Guide Selective Clamping and Tumor Dissection During Robot-assisted Partial Nephrectomy: A Preliminary Experience 329
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study 323
Locally advanced rectal cancer: T2w-MRI-based radiomics may detect responder patients undergoing neoadjuvant chemoradiotherapy 318
Efficacy of radioembolization according to tumor morphology and portal vein thrombosis inintermediate-advanced hepatocellular carcinoma 315
Human, All Too Human? An All-Around Appraisal of the “Artificial Intelligence Revolution” in Medical Imaging 315
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES 306
Il rischio clinico: gestire o farsi gestire? 302
Monofocal hepatocellular carcinoma: How much does size matter? 302
Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer 300
Optimization of pineapple juice amount used as a negative oral contrast agent in magnetic resonance cholangiopancreatography 297
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 294
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC 291
Real-time Augmented Reality Three-dimensional Guided Robotic Radical Prostatectomy: Preliminary Experience and Evaluation of the Impact on Surgical Planning 287
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 279
Radiomic features disclose the presence of microvascular invasion in hepatocellular carcinoma 278
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver 276
Ablation for hepatocellular carcinoma: beyond the standard indications 272
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 266
Heterogeneity of skewness in T2w-MR images of locally advanced rectal cancer relates with response to neoadjuvant chemoradiotherapy 265
Mild autonomous cortisol secretion in adrenal incidentalomas and risk of fragility fractures: a large cross-sectional study 264
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma. 264
Can imaging predict subclinical cortisol secretion in patients with adrenal adenomas? A CT predictive score 261
Comparison of transvaginal sonography and computed tomography €“colonography with contrast media and urographic phase for diagnosing deep infiltrating endometriosis of the posterior compartment of the pelvis: a pilot study 260
Development of a K-edge micro CT for the study of tumor angiogenesis in small animals 257
Sex-related penile fracture with complete urethral rupture: A case report and review of the literature 257
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 256
Machine Learning Pipeline for the Automated Prediction of MicrovascularInvasion in HepatocellularCarcinomas 255
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 255
[18F]-FDG PET/CT for suspected lymphoma relapse in a patient with concomitant pneumococcal pneumonia during COVID-19 outbreak: unexpected SARS-Cov-2 co-infection despite double RT-PCR negativity 255
The Heterogeneity of Skewness in T2W-Based Radiomics Predicts the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer 255
Transjugular intrahepatic portosystemic shunt: elective management of acute bleeding varices in a pregnant woman 253
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study 251
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 249
Ablazione percutanea ecoguidata mediante radiofrequenza di piccoli noduli di HCC: fattori correlati all'esito clinico e alla recidiva di malattia 248
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 246
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 246
Pattern of macrovascular invasion in hepatocellular carcinoma 246
Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisation 244
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 243
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group. 242
Computerized tomography texture analysis of pheochromocytoma: relationship with hormonal and histopathological data 240
Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging 239
Computed Tomography-Colonography With Intravenous Contrast Medium and Urographic Phase for the Evaluation of Pelvic Deep Infiltrating Endometriosis of Intestinal and Urinary Tract 239
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. 238
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 237
Chronic prostatitis/pelvic pain syndrome: MRI findings and clinical correlations. 237
Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report 236
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 234
A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor. 232
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics 231
The duration of the conventional chemoembolization for hepatocellular carcinoma: factors affecting the procedural time 230
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 230
Effectiveness of Radiomic ZOT Features in the Automated Discrimination of Oncocytoma from Clear Cell Renal Cancer 228
Can the multiphasic computed tomography (CT) scan be useful in the clinical management of small renal masses? 228
The changing scenario of hepatocellular carcinoma in Italy: an update 227
PTFE Grafts Versus Tunneled Cuffed Catheters for Hemodialysis: Which Is the Second Choice When Arteriovenous Fistula Is Not Feasible? 226
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 226
Combined Aldosterone and Cortisol Secretion by Adrenal Incidentaloma 225
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 225
Complete Remission of Advanced Hepatocellular Carcinoma Treated with Sorafenib and Concomitant Appearance of IgG4- related Diseases. A Case Report 225
Dynamic FDG PET/CT on bladder paraganglioma: A case report 223
Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies. 222
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 222
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 222
Accuracy of endorectal Magnetic Resonance Imaging (MRI) and Dynamic Contrast-Enhanced-MRI (DCE-MRI) in the preoperative local staging of prostate cancer. 220
Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma 219
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma 219
La Risonanza Magnetica con doppio contrasto (Gadolinio + Ferucarbotran) può sostituire la TC Spirale come seconda metodica d'imaging nella diagnosi del piccolo epatocarcinoma 219
Initiative on Superselective Conventional Transarterial Chemoembolization Results (INSPIRE) 218
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 217
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 217
Automatically extracted machine learning features from preoperative CT to early predict microvascular invasion in HCC: the role of the Zone of Transition (ZOT) 217
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 216
The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk 216
Indocyanine green as a predictor of clinically significant portal hypertension in a prospective cohort study of patients with chronic liver disease 215
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 214
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 214
An unusual spontaneous recanalization by multiple palmar arteriovenous connections of a chronically occluded radiocephalic hemodialysis fistula 213
Can testis-sparing surgery for small testicular masses be considered a valid alternative to radical orchiectomy? A prospective single-center study 213
Differential diagnosis between focal nodular hyperplasia and hepatocellular adenoma: Potential role of double tracer PET with 11C-Acetate and 18F-FDG 213
PERCUTANEOUS TREATMENT OF BILIARY AND VASCULAR COMPLICATIONS 212
LE PROPRIETÀ NASCOSTE NELL’IMMAGINE RM PER RILEVARE AUTOMATICAMENTE LA ZONA DI TRANSIZIONE TRA CARCINOMA RETTALE LOCALMENTE AVANZATO E TESSUTO SANO, E PREDIRE LA RISPOSTA ALLA TERAPIA NEO-ADIUVANTE 211
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 210
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 209
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 209
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 208
Totale 37.643
Categoria #
all - tutte 306.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 306.861


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202210.496 0 408 439 735 1.119 603 271 952 551 504 2.805 2.109
2022/202313.078 1.135 1.688 670 1.539 931 1.009 483 804 2.311 540 1.010 958
2023/20247.070 543 868 551 639 502 973 459 508 399 556 579 493
2024/202519.215 1.062 2.751 1.646 1.468 2.525 1.227 1.631 931 624 1.271 913 3.166
2025/202641.261 3.782 3.677 3.229 2.794 3.585 2.924 5.175 2.121 7.264 3.331 1.981 1.398
2026/20272.995 1.174 1.821 0 0 0 0 0 0 0 0 0 0
Totale 116.120